Panel Discussion
Time: 4:30 pm - 5:00 pm
day: Day One
Details:
- Hear from large pharma, investors, and experienced biotech leaders as they dive into the scientific and commercial factors of a setting up a successful partnership to develop GLP-1 based therapeutics for indications in obesity and beyond
- Uncover the key end-to-end key milestones that are evaluated when deciding on investment and partnership opportunities
- Ask your questions on what big pharma companies will be looking for next in their obesity and metabolism portfolios
